Excessive rest time during active phase is reliably detected in a mouse model of myotonic dystrophy type 1 using home cage monitoring

Myotonic dystrophy type 1 (DM1) is a dominantly inherited neuromuscular disease caused by the abnormal expansion of CTG-repeats in the 3′-untranslated region of the Dystrophia Myotonica Protein Kinase (DMPK) gene, characterized by multisystemic symptoms including muscle weakness, myotonia, cardio-re...

Full description

Bibliographic Details
Main Authors: Elisabetta Golini, Mara Rigamonti, Marcello Raspa, Ferdinando Scavizzi, Germana Falcone, Genevieve Gourdon, Silvia Mandillo
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Behavioral Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnbeh.2023.1130055/full
_version_ 1811161942620897280
author Elisabetta Golini
Mara Rigamonti
Marcello Raspa
Ferdinando Scavizzi
Germana Falcone
Genevieve Gourdon
Silvia Mandillo
author_facet Elisabetta Golini
Mara Rigamonti
Marcello Raspa
Ferdinando Scavizzi
Germana Falcone
Genevieve Gourdon
Silvia Mandillo
author_sort Elisabetta Golini
collection DOAJ
description Myotonic dystrophy type 1 (DM1) is a dominantly inherited neuromuscular disease caused by the abnormal expansion of CTG-repeats in the 3′-untranslated region of the Dystrophia Myotonica Protein Kinase (DMPK) gene, characterized by multisystemic symptoms including muscle weakness, myotonia, cardio-respiratory problems, hypersomnia, cognitive dysfunction and behavioral abnormalities. Sleep-related disturbances are among the most reported symptoms that negatively affect the quality of life of patients and that are present in early and adult-onset forms of the disease. DMSXL mice carry a mutated human DMPK transgene containing >1,000 CTGrepeats, modeling an early onset, severe form of DM1. They exhibit a pathologic neuromuscular phenotype and also synaptic dysfunction resulting in neurological and behavioral deficits similar to those observed in patients. Additionally, they are underweight with a very high mortality within the first month after birth presenting several welfare issues. To specifically explore sleep/rest-related behaviors of this frail DM1 mouse model we used an automated home cage-based system that allows 24/7 monitoring of their activity non-invasively. We tested male and female DMSXL mice and their wild-type (WT) littermates in Digital Ventilated Cages (DVCR) assessing activity and rest parameters on day and night for 5 weeks. We demonstrated that DMSXL mice show reduced activity and regularity disruption index (RDI), higher percentage of zero activity per each hour and longer periods of rest during the active phase compared to WT. This novel rest-related phenotype in DMSXL mice, assessed unobtrusively, could be valuable to further explore mechanisms and potential therapeutic interventions to alleviate the very common symptom of excessive daytime sleepiness in DM1 patients.
first_indexed 2024-04-10T06:22:02Z
format Article
id doaj.art-cb5aa180ebb8459ebfc0f7d283fb6e4e
institution Directory Open Access Journal
issn 1662-5153
language English
last_indexed 2024-04-10T06:22:02Z
publishDate 2023-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Behavioral Neuroscience
spelling doaj.art-cb5aa180ebb8459ebfc0f7d283fb6e4e2023-03-02T04:30:05ZengFrontiers Media S.A.Frontiers in Behavioral Neuroscience1662-51532023-03-011710.3389/fnbeh.2023.11300551130055Excessive rest time during active phase is reliably detected in a mouse model of myotonic dystrophy type 1 using home cage monitoringElisabetta Golini0Mara Rigamonti1Marcello Raspa2Ferdinando Scavizzi3Germana Falcone4Genevieve Gourdon5Silvia Mandillo6Institute of Biochemistry and Cell Biology (IBBC), National Research Council (CNR), Monterotondo, ItalyTecniplast S.p.A., Buguggiate, ItalyInstitute of Biochemistry and Cell Biology (IBBC), National Research Council (CNR), Monterotondo, ItalyInstitute of Biochemistry and Cell Biology (IBBC), National Research Council (CNR), Monterotondo, ItalyInstitute of Biochemistry and Cell Biology (IBBC), National Research Council (CNR), Monterotondo, ItalySorbonne Université, INSERM, Institut de Myologie, Centre de Recherche en Myologie, Paris, FranceInstitute of Biochemistry and Cell Biology (IBBC), National Research Council (CNR), Monterotondo, ItalyMyotonic dystrophy type 1 (DM1) is a dominantly inherited neuromuscular disease caused by the abnormal expansion of CTG-repeats in the 3′-untranslated region of the Dystrophia Myotonica Protein Kinase (DMPK) gene, characterized by multisystemic symptoms including muscle weakness, myotonia, cardio-respiratory problems, hypersomnia, cognitive dysfunction and behavioral abnormalities. Sleep-related disturbances are among the most reported symptoms that negatively affect the quality of life of patients and that are present in early and adult-onset forms of the disease. DMSXL mice carry a mutated human DMPK transgene containing >1,000 CTGrepeats, modeling an early onset, severe form of DM1. They exhibit a pathologic neuromuscular phenotype and also synaptic dysfunction resulting in neurological and behavioral deficits similar to those observed in patients. Additionally, they are underweight with a very high mortality within the first month after birth presenting several welfare issues. To specifically explore sleep/rest-related behaviors of this frail DM1 mouse model we used an automated home cage-based system that allows 24/7 monitoring of their activity non-invasively. We tested male and female DMSXL mice and their wild-type (WT) littermates in Digital Ventilated Cages (DVCR) assessing activity and rest parameters on day and night for 5 weeks. We demonstrated that DMSXL mice show reduced activity and regularity disruption index (RDI), higher percentage of zero activity per each hour and longer periods of rest during the active phase compared to WT. This novel rest-related phenotype in DMSXL mice, assessed unobtrusively, could be valuable to further explore mechanisms and potential therapeutic interventions to alleviate the very common symptom of excessive daytime sleepiness in DM1 patients.https://www.frontiersin.org/articles/10.3389/fnbeh.2023.1130055/fullDVC®DMSXLDM1digital biomarkersleepexcessive daytime sleepiness (EDS)
spellingShingle Elisabetta Golini
Mara Rigamonti
Marcello Raspa
Ferdinando Scavizzi
Germana Falcone
Genevieve Gourdon
Silvia Mandillo
Excessive rest time during active phase is reliably detected in a mouse model of myotonic dystrophy type 1 using home cage monitoring
Frontiers in Behavioral Neuroscience
DVC®
DMSXL
DM1
digital biomarker
sleep
excessive daytime sleepiness (EDS)
title Excessive rest time during active phase is reliably detected in a mouse model of myotonic dystrophy type 1 using home cage monitoring
title_full Excessive rest time during active phase is reliably detected in a mouse model of myotonic dystrophy type 1 using home cage monitoring
title_fullStr Excessive rest time during active phase is reliably detected in a mouse model of myotonic dystrophy type 1 using home cage monitoring
title_full_unstemmed Excessive rest time during active phase is reliably detected in a mouse model of myotonic dystrophy type 1 using home cage monitoring
title_short Excessive rest time during active phase is reliably detected in a mouse model of myotonic dystrophy type 1 using home cage monitoring
title_sort excessive rest time during active phase is reliably detected in a mouse model of myotonic dystrophy type 1 using home cage monitoring
topic DVC®
DMSXL
DM1
digital biomarker
sleep
excessive daytime sleepiness (EDS)
url https://www.frontiersin.org/articles/10.3389/fnbeh.2023.1130055/full
work_keys_str_mv AT elisabettagolini excessiveresttimeduringactivephaseisreliablydetectedinamousemodelofmyotonicdystrophytype1usinghomecagemonitoring
AT mararigamonti excessiveresttimeduringactivephaseisreliablydetectedinamousemodelofmyotonicdystrophytype1usinghomecagemonitoring
AT marcelloraspa excessiveresttimeduringactivephaseisreliablydetectedinamousemodelofmyotonicdystrophytype1usinghomecagemonitoring
AT ferdinandoscavizzi excessiveresttimeduringactivephaseisreliablydetectedinamousemodelofmyotonicdystrophytype1usinghomecagemonitoring
AT germanafalcone excessiveresttimeduringactivephaseisreliablydetectedinamousemodelofmyotonicdystrophytype1usinghomecagemonitoring
AT genevievegourdon excessiveresttimeduringactivephaseisreliablydetectedinamousemodelofmyotonicdystrophytype1usinghomecagemonitoring
AT silviamandillo excessiveresttimeduringactivephaseisreliablydetectedinamousemodelofmyotonicdystrophytype1usinghomecagemonitoring